Yes. The wacky back-seat epidemiology is new with the many vaccine candidates. Most people won't get an actual choice, they'll be offered what their healthcare provider offers and they can take it or leave it.
Well typically there isn't such a large gap in vaccine performance.
62% is about as bad as vaccines get, and in any other circumstance the manufacturer would retrial instead of seek approval. Even the WHO recommends a 70% minimum during pandemic times (with 50%+ being a measure of last resort, which I guess we're at now).
On the other hand, 95% is better than the best of the best.
62% is about as bad as vaccines get, and in any other circumstance the manufacturer would retrial instead of seek approval. Even the WHO recommends a 70% minimum during pandemic times (with 50%+ being a measure of last resort, which I guess we're at now).
On the other hand, 95% is better than the best of the best.